Novartis Pharmaceuticals Canada Inc. (“Novartis”) brought an application pursuant to s. 6 of the Patented Medicines (Notice of Compliance) Regulations for an...
March 22, 2013
AstraZeneca Canada Inc. and AstraZeneca UK Limited (“AstraZeneca”) brought an application pursuant to section 6 of the Patented Medicines (Notice of Compliance)...
March 20, 2013
Apotex Inc. (“Apotex”) brought an action for impeachment seeking a declaration that Lundbeck’s Canadian Patent No. 1,339,452 (the “’452 Patent”) is invalid.
March 18, 2013
Today the Canadian Government announced the introduction of a bill to amend the Trade-marks and Copyright Act to combat counterfeiting.
March 01, 2013
Teva Canada Limited (“Teva”) and Apotex Inc. (“Apotex”) wish to sell generic versions of GLEEVEC®, a highly effective drug for the treatment of chronic myeloid...
February 26, 2013
This was an appeal from a decision of the Federal Court granting Celgene Inc.’s (“Celgene”) application for judicial review and quashing a decision of the...
February 21, 2013
Eli Lilly Canada Inc. (“Lilly”) brought an application under the Patented Medicines (Notice of Compliance) Regulations (the “NOC Regulations”) for an Order...
January 28, 2013
This was an appeal from the decision of the Federal Court which had dismissed Takeda’s application for judicial review of the Minister’s refusal to list Takeda’s...
January 23, 2013
This is the first proceeding under the Patented Medicine (Notice of Compliance Regulations) (“NOC Regulations”) brought by Apotex Inc.
January 22, 2013
The Quebec government recently announced, as part of its budget, the intended abolishment of the rule known as “BAP-15.”
January 11, 2013
Try searching our global site instead